Literature DB >> 1994910

Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout.

E Pascual1.   

Abstract

Synovial fluid (SF) from 74 asymptomatic knees of patients with gout was analyzed. These patients had never been treated with serum uric acid-lowering agents. SF samples were analyzed for the presence of crystals and for cell counts, using undiluted SF directly in a Niebauer cell counting chamber. Thirty-seven of the aspirated knees had previously been inflamed, and monosodium urate (MSU) crystals were seen in SF aspirates from 36 of them (97%). Of the 37 knees that had never been inflamed, only 8 contained MSU crystals (P less than 0.00001). After reaching the joint, MSU crystals will persist in the SF as long as the serum uric acid level has not been lowered by appropriate treatment. In this situation, analysis of SF is an excellent diagnostic test for the intercritical gout. The mean cell count in the 44 SF samples that contained MSU crystals was 449/mm3 (95% confidence interval 310-589); the mean cell count in the 30 SF without MSU crystals was 64/mm3 (95% confidence interval 34-95) (P less than 0.00002). The SF samples that contained MSU crystals also had a higher percentage of polymorphonuclear leukocytes than those without MSU crystals (P less than 0.002). These data suggest that there is a low-grade inflammation present in the knees of patients with MSU crystals, the consequences of which should be investigated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1994910     DOI: 10.1002/art.1780340203

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  40 in total

Review 1.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Diagnosis and management of gout: a rational approach.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

3.  Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout.

Authors:  Eliseo Pascual; Francisca Sivera
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 4.  An old disease with new insights: Update on diagnosis and treatment of gout.

Authors:  Berivan Bitik; M Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2014-06-01

Review 5.  Managing Gout in the Patient with Renal Impairment.

Authors:  Eliseo Pascual; Francisca Sivera; Mariano Andrés
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

6.  Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.

Authors:  Young Hee Rho; Na Lu; Christine E Peloquin; Ada Man; Yanyan Zhu; Yuqing Zhang; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2014-10-02       Impact factor: 19.103

7.  Subclinical atherosclerosis in gouty arthritis patients: a comparative study.

Authors:  Selçuk Çukurova; Ömer Nuri Pamuk; Ercüment Ünlü; Gülsüm Emel Pamuk; Necati Çakir
Journal:  Rheumatol Int       Date:  2011-03-27       Impact factor: 2.631

Review 8.  Optimizing current treatment of gout.

Authors:  Frances Rees; Michelle Hui; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

9.  Goals of gout treatment: a patient perspective.

Authors:  Jasvinder A Singh
Journal:  Clin Rheumatol       Date:  2018-08-04       Impact factor: 2.980

10.  Interleukin-1beta gene polymorphisms in Taiwanese patients with gout.

Authors:  Man-Ling Chen; Chung-Ming Huang; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2003-12-06       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.